Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.
Biolinq has raised $100.0M in total funding. The most recent round was Series C. The last funding was announced in March 2025.
Biolinq's investors include Alpha Wave Global, Pegasus Tech Ventures, LifeSci Venture Partners, RiverVest, Longevity Vision Fund.
Biolinq is headquartered in San Diego, United States.
Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.
Biolinq is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biolinq — Funding & Investors." VCBacked, March 19, 2025, https://www.vcbacked.co/company/biolinq. Accessed November 15, 2026.
VCBacked. (2025). Biolinq — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/biolinq
{{cite web |title=Biolinq — Funding & Investors |url=https://www.vcbacked.co/company/biolinq |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Biolinq? Request a listing update